220. Rapidly progressive glomerulonephritis Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 0 / Drug : 0 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0
| Other names | RPGN;Necrotizing crescentic glomerulonephritis;NCGN;Glomerulonephritis; | ||
|---|---|---|---|
| Disease group | Kidney and urinary diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
1,440 patients Age distribution
 💬 |
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 2-2-16. rapidly progressive glomerulonephritis due to Microscopic Poly-angitis (MPA) | ||
| 2-2-17. rapidly progressive glomerulonephritis due to Granulomatosis with polyangiitis (GPA) | |||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | - | ||